SMi Reports: Interview excerpt with Bionical EMAS’ Executive VP, Tom Watson releasedfor SMi’s 9th Annual Conference on Orphan Drugs & Rare Diseases, in London in less than 3 weeks With less than 3 weeks left […]
SMI Reports: Overview of networking opportunities and key features to expect from the upcoming HPAPI USA conference 2019, in Boston With is less than 4 weeks until the 2019 HPAPI USA Conference 2019 taking place […]
Concert Pharmaceuticals announced that it has completed patient enrollment of an open label clinical trial to evaluate once-daily 24 mg compared to twice-daily 12 mg oral dosing of CTP-543 in patients with alopecia areata. Topline […]
Novartis said that the phase 3 trial of its psoriasis drug Cosentyx (secukinumab), called PREVENT, in patients with non-radiographic axial spondyloarthritis (nr-axSpA), has met its primary endpoint at Week 16. The PREVENT trial is assessing […]
Ironwood Pharmaceuticals, a GI healthcare company, announced today that it has amended its collaboration agreement with AstraZeneca for the development and commercialization of LINZESS in China. LINZESS was approved by the National Medical Products Administration […]